Skip to Main content Skip to Navigation
Journal articles

End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo

Abstract : End-binding 1 protein (EB1) is a key player in the regulation of microtubule (MT) dynamics. Here, we investigated the role of EB1 in glioblastoma (GBM) tumor progression and its potential predictive role for response to Vinca-alkaloid chemotherapy. Immunohistological analysis of the 109 human GBM cases revealed that EB1 overexpression correlated with poor outcome including progression-free survival and overall survival. Downregulation of EB1 by shRNA inhibited cell migration and proliferation in vitro. Conversely, EB1 overexpression promoted them and accelerated tumor growth in orthotopically-transplanted nude mice. Furthermore, EB1 was largely overexpressed in stem-like GBM6 that display in vivo a higher tumorigenicity with a more infiltrative pattern of migration than stem-like GBM9. GBM6 showed strong and EB1-dependent migratory potential. The predictive role of EB1 in the response of GBM cells to chemotherapy was investigated. Vinflunine and vincristine increased survival of EB1-overexpressing U87 bearing mice and were more effective to inhibit cell migration and proliferation in EB1-overexpressing clones than in controls. Vinca inhibited the increase of MT growth rate and growth length induced by EB1 overexpression. Altogether, our results show that EB1 expression level has a prognostic value in GBM, and that Vinca-alkaloid chemotherapy could improve the treatment of GBM patients with EB1-overexpressing tumor.
Complete list of metadatas

Cited literature [48 references]  Display  Hide  Download

https://hal-amu.archives-ouvertes.fr/hal-01310714
Contributor : Diane Braguer <>
Submitted on : Wednesday, May 4, 2016 - 3:49:20 PM
Last modification on : Thursday, May 9, 2019 - 1:56:15 PM
Long-term archiving on: : Tuesday, May 24, 2016 - 6:04:03 PM

File

Oncotarget2014Berges.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Raphael Berges, Nathalie Baeza-Kallee, Emeline Tabouret, Olivier Chinot, Marie Petit, et al.. End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo. Oncotarget, Impact journals, 2014, 5 (24), pp.12769-12787. ⟨10.18632/oncotarget.2646⟩. ⟨hal-01310714⟩

Share

Metrics

Record views

152

Files downloads

279